312 related articles for article (PubMed ID: 33664737)
1. Anti-Pentraxin Antibodies in Autoimmune Diseases: Bystanders or Pathophysiological Actors?
Brilland B; Vinatier E; Subra JF; Jeannin P; Augusto JF; Delneste Y
Front Immunol; 2020; 11():626343. PubMed ID: 33664737
[TBL] [Abstract][Full Text] [Related]
2. Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.
Augusto JF; Poli C; Beauvillain C; Subra JF; Jaillon S; Renier G; Chevailler A; Puéchal X; Delneste Y; Jeannin P
Int Rev Immunol; 2017 May; 36(3):145-153. PubMed ID: 28471269
[TBL] [Abstract][Full Text] [Related]
3. Pentraxins, anti-pentraxin antibodies, and atherosclerosis.
Bassi N; Zampieri S; Ghirardello A; Tonon M; Zen M; Cozzi F; Doria A
Clin Rev Allergy Immunol; 2009 Aug; 37(1):36-43. PubMed ID: 19016000
[TBL] [Abstract][Full Text] [Related]
4. Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
Simon A; Subra JF; Guilpain P; Jeannin P; Pignon P; Blanchard S; Garo E; Jaillon S; Chevailler A; Renier G; Puéchal X; Bottazzi B; Mantovani A; Delneste Y; Augusto JF
PLoS One; 2016; 11(1):e0147091. PubMed ID: 26797217
[TBL] [Abstract][Full Text] [Related]
5. Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.
Kravitz MS; Pitashny M; Shoenfeld Y
J Clin Immunol; 2005 Nov; 25(6):582-91. PubMed ID: 16380821
[TBL] [Abstract][Full Text] [Related]
6. Pattern recognition by pentraxins.
Agrawal A; Singh PP; Bottazzi B; Garlanda C; Mantovani A
Adv Exp Med Biol; 2009; 653():98-116. PubMed ID: 19799114
[TBL] [Abstract][Full Text] [Related]
7. PTX3 as a paradigm for the interaction of pentraxins with the complement system.
Inforzato A; Doni A; Barajon I; Leone R; Garlanda C; Bottazzi B; Mantovani A
Semin Immunol; 2013 Feb; 25(1):79-85. PubMed ID: 23747040
[TBL] [Abstract][Full Text] [Related]
8. The long pentraxin PTX3: a paradigm for humoral pattern recognition molecules.
Mantovani A; Valentino S; Gentile S; Inforzato A; Bottazzi B; Garlanda C
Ann N Y Acad Sci; 2013 May; 1285():1-14. PubMed ID: 23527487
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against protective molecules--C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus.
Shoenfeld Y; Szyper-Kravitz M; Witte T; Doria A; Tsutsumi A; Tatsuya A; Dayer JM; Roux-Lombard P; Fontao L; Kallenberg CG; Bijl M; Matthias T; Fraser A; Zandman-Goddard G; Blank M; Gilburd B; Meroni PL
Ann N Y Acad Sci; 2007 Jun; 1108():227-39. PubMed ID: 17899624
[TBL] [Abstract][Full Text] [Related]
10. [Pentraxins - their importance in pathogenesis of systemic lupus erythematosus].
Jakuszko K; Krajewska M; Weyde W; Grzegorczyk K; Klinger M
Postepy Hig Med Dosw (Online); 2011 Sep; 65():597-605. PubMed ID: 21918264
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the Complement System by Pentraxins.
Haapasalo K; Meri S
Front Immunol; 2019; 10():1750. PubMed ID: 31428091
[TBL] [Abstract][Full Text] [Related]
12. Pentraxins in nephrology: C-reactive protein, serum amyloid P and pentraxin-3.
Lech M; Rommele C; Anders HJ
Nephrol Dial Transplant; 2013 Apr; 28(4):803-11. PubMed ID: 23243042
[TBL] [Abstract][Full Text] [Related]
13. IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus.
Bassi N; Ghirardello A; Blank M; Zampieri S; Sarzi-Puttini P; Mantovani A; Shoenfeld Y; Doria A
Ann Rheum Dis; 2010 Sep; 69(9):1704-10. PubMed ID: 20439287
[TBL] [Abstract][Full Text] [Related]
14. The long pentraxin PTX3 in vascular pathology.
Mantovani A; Garlanda C; Bottazzi B; Peri G; Doni A; Martinez de la Torre Y; Latini R
Vascul Pharmacol; 2006 Nov; 45(5):326-30. PubMed ID: 17023219
[TBL] [Abstract][Full Text] [Related]
15. Pentraxins and atherosclerosis: the role of PTX3.
Garlanda C; Bottazzi B; Moalli F; Deban L; Molla F; Latini R; Mantovani A
Curr Pharm Des; 2011; 17(1):38-46. PubMed ID: 21226667
[TBL] [Abstract][Full Text] [Related]
16. Pentraxins in innate immunity: lessons from PTX3.
Deban L; Jaillon S; Garlanda C; Bottazzi B; Mantovani A
Cell Tissue Res; 2011 Jan; 343(1):237-49. PubMed ID: 20683616
[TBL] [Abstract][Full Text] [Related]
17. Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.
Yuan M; Tan Y; Pang Y; Li YZ; Song Y; Yu F; Zhao MH
Ren Fail; 2017 Nov; 39(1):465-473. PubMed ID: 28393653
[TBL] [Abstract][Full Text] [Related]
18. Biological actions of pentraxins.
Vilahur G; Badimon L
Vascul Pharmacol; 2015 Oct; 73():38-44. PubMed ID: 25962566
[TBL] [Abstract][Full Text] [Related]
19. Pentraxins (CRP, SAP) in the process of complement activation and clearance of apoptotic bodies through Fcγ receptors.
Du Clos TW; Mold C
Curr Opin Organ Transplant; 2011 Feb; 16(1):15-20. PubMed ID: 21150611
[TBL] [Abstract][Full Text] [Related]
20. Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3.
Mantovani A; Garlanda C; Doni A; Bottazzi B
J Clin Immunol; 2008 Jan; 28(1):1-13. PubMed ID: 17828584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
